FDA Drug Review Deal unravels as Fiscal Cliff Looms
A $6.4B accord for US drug and medical-device reviews is set to unravel Read more…
A $6.4B accord for US drug and medical-device reviews is set to unravel Read more…
The FDA and the NIH launched a new website that, when fully developed, will provide a mechanism for the reporting of pre and post market safety data to the federal government. The new site, called the Safety Reporting Portal (SRP) will provide access to online reporting to analyze human and animal safety related events needed to protect the public. Read more…
Through its transparency initiative, the FDA has considered a wide range of options for increasing transparency about these and other aspects of its work. The task force (that includes senior leaders at the agency) believes that implementing some of the proposals would accelerate the development process for medical products by allowing companies to learn from the successes and failures of other products. Read more…

Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.